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Conclusions-Hyperlipidaemia is common in the second half of pregnancy. This may be a purely physiological response to pregnancy or it may be indicative of pathology in some women. These results warrant a follow up study to investigate whether the hyperlipidaemic response to pregnancy is variable and if so, whether it can predict future hyperlipidaemia in a manner analogous to that of impaired glucose tolerance during pregnancy, predicting non-insulin dependent diabetes in later life.
(T Clin Pathol 1994;47:728-731)
Hyperlipidaemia is a well established risk factor for coronary heart disease (CHD) in both men and women.lA Although pregnancy has been shown to increase serum total cholesterol and triglyceride,5-10 its effect on apolipoproteins and lipoprotein (a) (Lp(a)) has not been adequately characterised. Moreover, the prevalence and extent of these alterations and the underlying mechanisms have not been fully documented. In this preliminary report we present the results of lipid, lipoprotein, and apolipoprotein measurements performed on 178 healthy women in the second and third trimesters of pregnancy and compare these with those of non-pregnant women of similar age.
Methods
Fasting venous blood was collected from 178 women presenting consecutively for oral glucose tolerance tests in the second and third trimesters of pregnancy. All women had a normal glucose tolerance (two hour capillary plasma glucose of < 9-0 mmolIl following a 75 g oral glucose load)." The women attended for glucose tolerance tests for one or more of the following reasons: family history of diabetes (n = 80), glycosuria (n = 60), previous large baby (n = 31), polyhydramnios (n = 22), large for dates (n = 20), obesity (n = 14), previous gestational diabetes (n = 8), previous stillbirth (n = 20), recent miscarriage (n = 3) and hypertension (n = 2). No patient had clinical proteinuria or other evidence of secondary hyperlipidaemia.
The control group consisted of 58 nonpregnant female volunteers of similar age who were not taking oral contraceptives or receiving lipid-lowering treatment and who were not known to have diabetes. All subjects were in the sitting position for venesection which was carried out with minimal stasis. All women were consuming an unrestricted diet before the test.
Serum was analysed for cholesterol and triglyceride using enzymatic analysis on a DAX-96 analyser (Bayer Diagnostics, Basingstoke, Hants) (interassay CV of < 1-9% and < 2-8%, respectively). HDL Logarithms were taken of the data for triglyceride and Lp(a) to correct for positively skewed distributions. The mean concentrations obtained for the two groups were compared using the unpaired t test. One-way analysis of variance (ANOVA) was performed to detect differences in the concentrations of the lipids, lipoproteins, and apolipoproteins with advancing gestational age. Four women were excluded from ANOVA due to the gestational age being unavailable. The data were also analysed by multiple linear regression to take both subject age and gestational age into account.
Results Table 1 gives the clinical characteristics and laboratory results for the pregnant and control groups. With the exception of Lp(a) the lipid, lipoprotein, and apolipoprotein concentrations were significantly higher in the pregnant women than in the controls. The pregnant women had mean concentrations of total cholesterol, HDL cholesterol, LDL cholesterol and apolipoprotein AI which were about 30% greater than in the controls. The concentration of apolipoprotein B was 60% greater than in the controls. The most striking increase was that of triglyceride which was almost threefold greater in the pregnant women.
The percentage of pregnant women with concentrations of total cholesterol above 5-2, 6-5, and 7-8 mmol/l was 87%, 63%, and 20%, respectively, compared with 24%, 0%, and 0% for the controls. Forty four per cent of the pregnant women, but only three per cent of the controls, had concentrations of LDL cholesterol above 4 0 mmol/l. These concentrations are associated with an increased risk of CHD and are the treatment levels recommended by the British Hyperlipidaemia
Association. 14 Triglyceride (mmol/l)* 2-08(1-33, 2 with an increased risk of CHD. We have also shown that the concentrations of LDL and HDL cholesterol, and of their corresponding apolipoproteins B, and AI and AII, respectively, are increased in pregnancy. A novel finding was that the concentration of Lp(a) was not significantly increased during pregnancy.
The increases in total and LDL cholesterol and triglyceride are similar to those reported by others,5-10 but the increase in HDL cholesterol has not been widely observed Our study does have certain limitations. Firstly, the subjects were not observed longitudinally. Secondly, the pregnant group was highly selected, the subjects being recruited from women presenting for oral glucose tolerance tests. The results may therefore not be representative of the general population. However, women with impaired glucose tolerance were excluded from the study, and although the pregnant women may have been consuming a high carbohydrate diet which could account for the higher concentration of triglycerides, we are not aware that the nutrient intake varied significantly between the pregnant and control groups. Thirdly, recruitment from these patients has led to a clustering of subjects between the gestational ages of 27 and 33 weeks, thereby restricting the examination of the effects of gestational age. Fourthly, the concentration of LDL cholesterol was obtained by calculation, which assumes that the composition of lipoproteins in pregnancy is the same as in normal metabolic states. The calculated value also includes any IDL cholesterol. Finally, the subjects were not matched for the degree of obesity. These limitations could be overcome by a longitudinal study in randomly selected pregnant women with measurement of LDL and other cholesterol fractions by ultracentrifugation. In late pregnancy rising concentrations of prolactin inhibit adipose tissue lipoprotein lipase activity25 resulting in a rise in the concentration of plasma triglyceride. HPL has lipolytic activity26 which may increase substrate supply of free fatty acids for the increased maternal hepatic VLDL production. The hypertriglyceridaemia in late pregnancy may be further enhanced by hyperinsulinaemia due to insulin resistance which is known to be associated with higher concentrations of triglyceride. 27 Hypoalbuminaemia is a further possible contributory cause of hyperlipidaemia in pregnancy, but our subjects did not have sufficiently low serum albumin concentrations to result in secondary hyperlipidaemia.
It has been suggested that the alterations in lipid metabolism during gestation may be important in the control of delivery to and uptake of nutrients by the fetus, particularly during rapid fetal weight gain in the second half of gestation. During early pregnancy adipose stores are enlarged and used by the mother in late gestation so as to spare glucose for the fetus. Maternal hyperlipidaemia may therefore have a beneficial influence on fetal development. Whether the maternal hyperlipidaemia has any pathological importance is not known. A positive association between parity and European heart disease in later life has been reported2829 and a recent study has shown that lipid concentrations after delivery are higher, and that the total cholesterol to HDL cholesterol ratio is higher in women who have had five or more pregnancies compared with those who have had only one.'0 Our results suggest that in spite of the mitigating effect of increased HDL cholesterol concentrations, the increased apolipoprotein B: AI ratio may have an atherogenic effect. Pregnancy may also precipitate severe chylomicronaemia in women with the rare familial lipoprotein lipase deficiency3l or with other causes of hypertriglyceridaemia. Such women may be previously undiagnosed and may present with acute pancreatitis during pregnancy. Patients have been successfully managed by the exclusion or restriction of fat, and the measurement of lipids during pregnancy would enable those women at risk to be identified. Of additional interest is the possibility that the extent of the hyperlipidaemic response to pregnancy may be genetically determined. If this is so, measurement of lipids and lipoproteins during the third timester of pregnancy may provide a sensitive test for identifying women without overt hyperlipidaemia who are at risk of future coronary heart disease and of atheroma. This hypothesis needs to be evaluated in a follow up study of these women before routine screening for hyperlipidaemia in pregnancy can be recommended.
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